tiprankstipranks
Landos Biopharma (LABP)
NASDAQ:LABP
US Market

Landos Biopharma (LABP) Technical Analysis

92 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Landos Biopharma’s (LABP) Moving Averages Convergence Divergence (MACD) indicator is 3.10, suggesting Landos Biopharma is a Sell.
Landos Biopharma’s (LABP) 20-Day exponential moving average is 10.48, while Landos Biopharma’s (LABP) share price is $21.36, making it a Buy.
Landos Biopharma’s (LABP) 50-Day exponential moving average is 7.65, while Landos Biopharma’s (LABP) share price is $21.36, making it a Buy.

Landos Biopharma (LABP) Pivot Points

Mar 29, 2024, 01:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.91
21.13
21.35
21.57
21.79
22.01
22.23
Fibonacci
21.13
21.30
21.41
21.57
21.74
21.85
22.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Landos Biopharma (LABP) Moving Averages

Mar 29, 2024, 01:01 AM
Period
Simple
Exponential
MA5
15.96Buy
17.25Buy
MA10
11.35Buy
13.53Buy
MA20
8.90Buy
10.48Buy
MA50
6.74Buy
7.65Buy
MA100
5.44Buy
6.16Buy
MA200
4.64Buy
5.03Buy
Landos Biopharma’s (LABP) 10-Day exponential moving average is 13.53, while Landos Biopharma’s (LABP) share price is $21.36, making it a Buy.
Landos Biopharma’s (LABP) 100-Day exponential moving average is 6.16, while Landos Biopharma’s (LABP) share price is $21.36, making it a Buy.
Landos Biopharma’s (LABP) stock price is $21.36 and Landos Biopharma’s (LABP) 50-day simple moving average is 6.74, creating a Buy signal.
Landos Biopharma’s (LABP) stock price is $21.36 and Landos Biopharma’s (LABP) 100-day simple moving average is 5.44, creating a Buy signal.
Landos Biopharma’s (LABP) stock price is $21.36 and Landos Biopharma’s (LABP) 200-day simple moving average is 4.64, creating a Buy signal.

Landos Biopharma (LABP) Technical Indicators

Mar 29, 2024, 01:01 AM
Name
Value
Implied Action
RSI (14)
96.46
Sell
STOCH (9,6)
97.25
Sell
STOCHRSI (14)
97.37
Sell
MACD (12,26)
3.10
Sell
ADX (14)
37.41
Neutral
Williams %R
-3.12
Sell
CCI (14)
221.50
Sell
ATR (14)
1.28
-
Ultimate Oscillator
85.52
Buy
ROC
228.11
Buy
Landos Biopharma’s (LABP) Relative Strength Index (RSI) is 96.46, creating a Sell signal.
Landos Biopharma’s (LABP) Trend Strength Indicator (ADX) is 37.41, creating a Neutral signal.
Landos Biopharma’s (LABP) Commodity Channel Index (CCI) is 221.50, creating a Sell signal.
Landos Biopharma’s (LABP) Price Rate of Change (ROC) is 228.11, creating a Buy signal.

FAQ

Is LABP a Buy, Hold, or Sell?
Based on LABP’s technical indicators, LABP is a Buy.
    What is LABP’s RSI (14)?
    LABP’s RSI (14) is 96.46, which suggests LABP is a Sell.
      What is LABP’s MACD?
      LABP’s MACD is 3.10, which suggests LABP is a Sell.
        What is LABP’s 5-day moving average?
        LABP’s 5-day moving average is 15.96, which suggests LABP is a Buy.
          What is LABP’s 20-day moving average?
          LABP 20-day moving average is 8.90, which suggests LABP is a Buy.
            What is LABP’s 50-day moving average?
            LABP’s 50-day moving average is 6.74, which suggests LABP is a Buy.
              What is LABP’s 200-day moving average?
              LABP’s 200-day moving average is 4.64, which suggests LABP is a Buy.
                What is LABP’s Williams % R (14)?
                LABP’s Williams % R (14) is -3.12, which suggests LABP is a Sell.
                  What is LABP’s CCI (14)?
                  LABP’s CCI (14) is 221.50, which suggests LABP is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis